Rivastigmine Transdermal System NDC 63629-2065

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-2065Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-2065Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-2065-1	63629206501	30 POUCH in 1 CARTON (63629-2065-1) / 1 PATCH in 1 POUCH (63629-2065-2) / 24 h in 1 PATCHMarketed from Feb 11, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine Transdermal System
Generic name (nonproprietary): rivastigmine
Active ingredients: Rivastigmine — 4.6 mg/24h
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209063
Marketing start: Dec 19, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 63629-2065_514cd09f-04ed-46b0-8d34-802d6c0d969dSPL ID 514cd09f-04ed-46b0-8d34-802d6c0d969dSPL set ID 82630f84-fb47-47ab-8ee2-1720a486de02RxCUI 725021UNII PKI06M3IW0
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629206501 followed by a unit qualifier and the quantity

Package 63629-2065-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 209063

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209063
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	63629-8846
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Breckenridge Pharmaceutical, Inc.	51991-897
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Breckenridge Pharmaceutical, Inc.	51991-898
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Breckenridge Pharmaceutical, Inc.	51991-899
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	72162-1610
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	72162-1608
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	72162-1609
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	63629-2064
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	63629-2066
Rivastigmine Transdermal Systemrivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	63629-8807

Rivastigmine Transdermal System (rivastigmine) NDC 63629-2065